A PCR assay that allows simultaneous detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci (Enterococcus faecium, E. faecalis, E. gallinarum, and E. casseliflavus) was developed. This assay was based on specific amplification of internal fragments of genes encoding D-alanine:D-alanine ligases and related glycopeptide resistance proteins. The specificity of the assay was tested on 5 well-characterized glycopeptide-resistant strains and on 15 susceptible enterococcal type strains. Clinical isolates of enterococci that could not be identified to the species level by conventional methods were identified by the PCR test. This assay offers a specific and rapid alternative to antibiotic susceptibility tests, in particular for detection of low-level vancomycin resistance.
Enterococci are increasingly responsible for nosocomial infections such as endocarditis, bacteremia, urinary tract infections, or neonatal sepsis (28) . In a recent study these microorganisms represented the third most common cause of hospitalacquired bacteremia (28) . Of the 20 enterococcal species described to date (4), Enterococcus faecalis and E. faecium represent ca. 90% of clinical isolates belonging to this genus (13, 19) . E. gallinarum and E. casseliflavus are less represented, but the incidence of these species is underestimated because of frequent misidentification (33) . Proper identification of enterococci to the species level is important for appropriate therapy of certain infections, in particular endocarditis, because of species-specific differences in the susceptibility to ␤-lactams and glycopeptides (19) .
Glycopeptide resistance in enterococci is now a cause of clinical concern. Three glycopeptide resistance phenotypes can be distinguished on the basis of the level and inducibility of resistance to vancomycin and teicoplanin (1, 7) . The VanAtype is characterized by acquired inducible resistance to both vancomycin and teicoplanin (17, 32) . Strains of the VanB type have acquired inducible resistance to various levels of vancomycin but not to teicoplanin (24) . Constitutive low-level resistance to vancomycin (VanC type) is an intrinsic property of motile enterococci, E. gallinarum (18, 33) , E. casseliflavus (20, 33) , and E. flavescens (20) . Fourteen percent of enterococci isolated in the United States are glycopeptide resistant (30) . The actual prevalence might even be higher since phenotypic detection of low-level resistance is difficult (27, 31) . Several recent outbreaks of vancomycin-resistant enterococci (30, 32) emphasize the need for laboratories to be able to detect the various types of resistance.
The PCR has been extensively applied in medical diagnosis (4). It has been used for species identification of infectious agents (12, 16, 21) and specific detection of antibiotic resistance genes (23) . We have developed a PCR assay which allows identification of the four glycopeptide resistance genotypes described for enterococci (vanA, vanB, vanC-1, and vanC-2) together with identification to the species level of four clinically relevant species of enterococci (E. faecalis, E. faecium, E. gallinarum, and E. casseliflavus).
MATERIALS AND METHODS
Bacterial strains and culture conditions. Well-characterized glycopeptideresistant enterococci belonging to phenotypes VanA, VanB, and VanC were studied. These were E. faecium BM4147 (VanA) (17) , E. faecalis V583 (VanB) (26) , E. gallinarum BM4174 (VanC) (10), E. casseliflavus ATCC 25788 (VanC) (20) , and E. flavescens CCM 439 (VanC) (22 Computer analysis of sequence data. Nucleotide sequences were aligned with the Genetics Computer Group software (5) by using the progressive alignment method (15) . The GenBank database was screened to detect homology between the oligodeoxynucleotides used and known sequences.
PCR. Oligodeoxynucleotides were synthesized (Laboratoire de Chimie Organique, Institut Pasteur, Paris, France) by the methoxyphosphoramidite method on an Applied Biosystems (Foster City, Calif.) 380 DNA synthesizer. Total DNA was prepared by a rapid alkaline lysis method as described previously (8) . PCR was performed on a DNA thermal cycler (model 480; Perkin-Elmer Cetus, Emeryville, Calif.) in a final volume of 100 l containing 250 ng of DNA as template; 50 pmol of each oligodeoxynucleotide primer; 500 M (each) dATP, dCTP, dGTP, and dTTP; 67 mM Tris-HCl (pH 8.8); 7 mM MgCl 2 ; 17 mM ammonium sulfate; 10 mM ␤-mercaptoethanol; and 2 U of Taq DNA polymerase. The cycles used were 94ЊC for 2 min for the first cycle; 94ЊC for 1 min, 54ЊC for 1 min, and 72ЊC for 1 min for the next 30 cycles; and 72ЊC for 10 min for the last cycle. PCR products were resolved by electrophoresis on a 1.5% agarose-Tris-borate-EDTA gel containing 0.5 g of ethidium bromide per ml.
Enzymes and reagents. Lysozyme was purchased from Sigma Chemical Co. (St. Louis, Mo.). Taq DNA polymerase was obtained from Amersham (Little Chalfont, United Kingdom). Dideoxynucleotides, dATP, dCTP, dGTP, and dTTP, were obtained from Pharmacia (Uppsala, Sweden).
RESULTS AND DISCUSSION
Design of oligodeoxynucleotides. The use of PCR for simultaneous identification of enterococcal species and glycopeptide resistance genotypes was based on specific detection of genes We have shown that the ddl E. faecalis and ddl E. faecium genes are specific for E. faecalis (7) and E. faecium (unpublished results), respectively, whereas the vanA and vanB genes are associated with VanA (8) and VanB types (24) of glycopeptide resistance. The vanC-1, vanC-2, and vanC-3 genes are specific for E. gallinarum (18) , E. casseliflavus (20) , and E. flavescens (20) , respectively. In the PCR assay described, species identification of E. faecium, E. faecalis, and E. gallinarum relies on specific amplification of fragments intragenic to ddl E. faecium ddl E. faecalis , and vanC-1, respectively, whereas acquired glycopeptide resistance genotypes are identified by specific amplification of portions of the vanA and vanB genes. The vanC-2 and vanC-3 genes of E. casseliflavus and E. flavescens are almost identical (98% identity) (20) . A primer pair intended to amplify fragments internal to both genes was chosen. Thus, these two species which are phenotypically very similar are not distinguished by our assay. The nucleotide sequence of the ddl E. faecalis vanA, vanB, vanC-1, and vanC-2 genes and the partial sequence of the ddl E. faecium gene (unpublished results) were aligned (data not shown). Six pairs of oligodeoxynucleotides, each intended to prime amplification of a fragment internal to a gene, were selected in nonconserved regions. Table 1 shows positions and sequences of the oligodeoxynucleotides. Primers of similar size (17 to 19 bases) and GC content ranging from 37 to 53% were selected (Table 1) to avoid variations in annealing temperature and to allow simultaneous use of the six pairs in a single reaction. Each amplification product could be assigned to a gene on the basis of its size ( (Table 1) , were evaluated for their ability to amplify fragments intragenic to their targets. Each pair allowed specific amplification of a fragment of the predicted size from the corresponding DNA preparation only (data not shown). As an example, pair A yielded a band corresponding to 732 bp with DNA from E. faecium BM4147 (VanA) as a template but not with DNA from the other strains.
In a second step, PCR was performed with DNA from every strain as a template by using the six pairs of oligodeoxynucleotides simultaneously. One or two bands were generated, depending upon the template (Fig. 1) . Two PCR products with sizes of ca. 550 and 732 bp resulting from amplification of portions of the ddl E. faecium and vanA genes (Table 1) (Fig. 1, lane 3) or 439 bp (Fig. 1, lanes 4 and 5) corresponding to amplification of vanC-1, vanC-2, and vanC-3, respectively, was generated.
We investigated the specificity of the six primer pairs by testing reference strains of the 20 described enterococcal species. Amplification products with the expected sizes were obtained with DNA from E. faecium (Fig. 1, lane 11) and E. faecalis (data not shown). By contrast, the primer pairs did not amplify DNA from the other species (Fig. 1, lanes 7 to 10, and data not shown).
The PCR assay was then used on 26 clinical isolates of enterococci that could not be identified to the species level by API 50CH galleries (bioMérieux, Marcy l'Etoile, France). Species were identified for 23 strains including 13 E. faecalis strains, 7 E. faecium strains, and 3 E. gallinarum strains. No PCR product was observed with DNA from two strains, suggesting that they belong to enterococcal species other than those identified by our assay. PCR with DNA of the last strain generated a fragment with an unexpected size (ca. 590 bp) that is currently being sequenced. Genes vanA and vanB were not detected among the 26 clinical isolates.
Identification to the species level of enterococci is important, in particular for species that are intrinsically resistant to antibiotics (e.g., E. faecium to ␤-lactams or motile enterococci to vancomycin). Unfortunately, identification of E. faecium, E. gallinarum, and E. casseliflavus is based on physiological tests, such as motility at 30ЊC and yellow pigmentation (13) , that are not totally reliable (33) . In addition, it has been demonstrated in an animal model of endocarditis that low-level resistance of Enterococcus spp. to vancomycin results in therapeutic failure (14) . Finally, recent reports have documented the inability of several automated susceptibility testing systems (27, 31, 34) and disk-agar diffusion (27, 29, 31) to detect low-level vancomycin resistance in enterococci (strains with a VanC phenotype and certain strains of the VanB type). These observations emphasize the need for accurate identification of enterococcal species and detection of acquired or intrinsic glycopeptide resistance. Our PCR assay provides a specific and rapid alternative to phenotypic or DNA-DNA hybridization methods for detection of glycopeptide resistance, in particular to low levels of vancomycin, and for identification of clinically relevant enterococci.
